Table 3.

PRO patient population included in the PRO analyses.

PRO evaluable population definition	Trials (N = 17), n (%)
Safety population with baseline and at least one post-baseline assessment	1 (6)
Safety population	2 (12)
ITT patients with baseline and at least one post-baseline assessment	2 (12)
ITT	7 (41)
Patients with at least one post-baseline assessment and 50% completion of the relevant items for a domain	2 (12)
At least one assessment	2 (12)
ITT patients receiving active treatment and at least one PRO measurement item completed	1 (6)

ITT intent to treat.